博傑股份(002975.SZ):擬轉讓參股子公司蘇州焜原股權
格隆匯5月23日丨博傑股份(002975.SZ)公佈,公司董事會同意公司將持有的參股子公司蘇州焜原光電有限公司(簡稱“蘇州焜原”)1.8071%、0.6601%股權以20,000,004.33元、7,690,626.22元的轉讓價款分別轉讓給寧波潤璞創業投資合夥企業(有限合夥)(簡稱“寧波潤璞”)、蘇州焜芯創業投資合夥企業(有限合夥)(簡稱“焜芯創投”),轉讓完成後,公司仍持有蘇州焜原4.4708%的股權。經公司初步測算,本次交易產生的利潤預計4,479萬元左右(該數據未經審計,最終對損益的影響數據以會計師審計後的爲準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.